Zoetis broke ground in April of 2018 on a 463,000-sf animal vaccine center in Suzhou, China. Combining research and development operations with integrated manufacturing and supply, the facility will produce vaccines for swine, cattle, fish, and companion animals. Offering sophisticated innovation suites and certified GMP laboratories, the project will support research on disease threats prevalent in China with a primary focus on aquaculture. Accommodating the production of viral and bacterial vaccines, the center will include pilot scale manufacturing systems for the development of new products. The project will house approximately 100 new employees and is expected to reach completion by 2021.